As a result, there has been a shift in focus from the scientific community to industry and politicians.
The International Council of Scientific Research (ICSR), an organisation which supports scientists and industry, said it was concerned that the UK’s National Health Service’s (NHS) reforms had made the UK less competitive with other countries in the field.
It cited the lack of quality control measures as a major cause of the “inadequate” outcomes in the UK.
“A key question to ask is why there is a lack of regulation of quality,” said Dr Robert Smith, ICSR’s chief executive.
“What is the rationale for the absence of such regulation?
We know that quality is a key driver of innovation and productivity, so it is important to ensure that our scientific research is conducted with the highest standards.”
A spokesman for the Ministry of Health said the government was committed to the promotion of science in the NHS.
“We have introduced new standards to protect public health, and we are working with industry and the wider health sector to ensure the best standards of care are put in place,” he said.
“Our approach is to provide industry with the best value for money.”
The Royal Society said it had warned the government about the need for the UK to reform its scientific standards, but had not seen the evidence to back up that claim.
“This is a concern for us, but we also know that we can always rely on the quality of research that’s produced by our own scientists and our own researchers,” said Professor Simon Pritchard, who leads the Royal Society’s scientific research unit.
“If the quality standards that exist in the US are inadequate, we need to get the US to do the same.”